| 1978N-0065 | Skin Bleaching Drug Products | |||||||||||||||||||||||
| FDA Comment Number : | EC315 | |||||||||||||||||||||||
| Submitter : | Mrs. Beverly Aldridge | Date & Time: | 12/21/2006 09:12:30 | |||||||||||||||||||||
| Organization : | Mrs. Beverly Aldridge | |||||||||||||||||||||||
| Category : | Health Professional | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| I have used the Obagi products under the supervision of a Dermatologist without any adverse reaction for the last 6 months and will continue to do so. Obagi has been on the market for many years and there is data that supports this is a great product for people with melasma. The products being sold OTC and not under the supervision of a Dermatologist needs to have stricter guidelines. | ||||||||||||||||||||||||